Kevin Lee
CHIEF EXECUTIVE OFFICER, Director · BICYCLE THERAPEUTICS PLC
- 2024
- Oct 6, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kevin Lee files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael Skynner - $31K in BCYC purchases and sales in the last 12 months
- Michael Charles Ferguson Hannay - $23K in BCYC purchases and sales in the last 12 months
- Jennifer Scott Perry - $20K in BCYC purchases and sales in the last 12 months
- Robert Charles Swanton - $12K in BCYC purchases and sales in the last 12 months
- Travis Alvin Thompson - $12K in BCYC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kevin Lee?
Kevin Lee is a corporate insider, tracked as CHIEF EXECUTIVE OFFICER, Director of BICYCLE THERAPEUTICS PLC (BCYC). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Kevin Lee submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Kevin Lee been buying or selling stock?
Recorded transactions: 0 open-market purchases and 11 open-market sales ($255K) across all tracked filings.
